Amgen Inc.
AMGN
$312.47
-$2.25-0.72%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.11% | 8.50% | 4.52% | 2.91% | 1.96% |
| Total Other Revenue | 5.97% | -15.90% | -33.48% | -29.03% | -32.23% |
| Total Revenue | 12.76% | 7.09% | 1.91% | 0.75% | -0.48% |
| Cost of Revenue | 51.26% | 31.91% | 11.10% | 7.35% | 0.61% |
| Gross Profit | -0.12% | -0.89% | -1.03% | -1.36% | -0.84% |
| SG&A Expenses | 23.37% | 13.89% | 3.74% | 2.38% | 1.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 11.90% | 48.53% | -66.73% | -62.57% | 22,866.67% |
| Total Operating Expenses | 30.33% | 20.13% | 3.81% | 0.45% | 3.30% |
| Operating Income | -21.03% | -15.91% | -1.36% | 1.29% | -7.02% |
| Income Before Tax | -52.32% | 6.93% | 13.22% | 22.74% | 39.79% |
| Income Tax Expenses | -51.34% | 43.32% | 32.55% | 32.86% | 50.25% |
| Earnings from Continuing Operations | -52.47% | 2.52% | 10.69% | 21.34% | 38.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.47% | 2.52% | 10.69% | 21.34% | 38.34% |
| EBIT | -21.03% | -15.91% | -1.36% | 1.29% | -7.02% |
| EBITDA | -6.35% | -6.65% | 0.86% | 2.30% | -4.59% |
| EPS Basic | -52.50% | 3.15% | 12.86% | 25.87% | 45.11% |
| Normalized Basic EPS | -48.60% | -32.95% | -9.47% | -11.02% | -8.03% |
| EPS Diluted | -52.37% | 3.23% | 12.78% | 25.62% | 44.72% |
| Normalized Diluted EPS | -48.53% | -32.97% | -9.58% | -11.14% | -8.10% |
| Average Basic Shares Outstanding | 0.09% | -0.65% | -1.88% | -3.30% | -4.93% |
| Average Diluted Shares Outstanding | -0.05% | -0.55% | -1.78% | -3.19% | -4.86% |
| Dividend Per Share | 8.68% | 9.79% | 9.89% | 10.00% | 10.11% |
| Payout Ratio | 1.29% | 0.06% | -0.03% | -0.13% | -0.25% |
